Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vicore Pharma Holding AB (publ)
VICOCurrent price
7.98 SEK
-0.13 SEK (-1.60%)
Last closed
8.19 SEK
Company
www.vicorepharma.com
ISIN
SE0007577895
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
1 931 226 913 SEK
Yield for 12 month
-41.58 %
1Y
3Y
5Y
10Y
15Y
VICO
Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases. It develops C21, an orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) that is in Phase II clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF), as well as in Phase I clinical trial for treating pulmonary arterial hypertension. The company is also developing Almee, an investigational medical device in clinical development that has completed Phase III clinical stage to address the psychological impact of living with pulmonary fibrosis. Vicore Pharma Holding AB (publ) has a cooperation and development agreement with Emeriti Bio AB and HaLaCore Pharma AB to develop new follow-on molecules based on C21 and other drug substances targeting the AT2 receptor, as well as a collaboration and development agreement with Alex Therapeutics AB to develop a digital app in interstitial lung diseases, such as IPF. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Stockholm, Sweden. Address: Kornhamnstorg 53, Stockholm, Sweden, 111 27
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
319.54 SEKP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 468 494 SEK
Last Year
-3 662 152 SEK
Current Quarter
-568 794 SEK
Last Quarter
-850 652 SEK
Key Figures VICO
1 year
3 years
5 years
10 years
EBITDA
-222 489 684 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.01 %
PEG Ratio
–
Return On Equity TTM
-54.29 %
Wall Street Target Price
319.54 SEK
Revenue TTM
105 690 275 SEK
Book Value
4.13 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.73 SEK
Diluted Eps TTM
-1.73 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-191.92 %
Dividend Analytics VICO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VICO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
37:36
Payout Ratio
–
Last Split Date
17.09.2024
Dividend Date
–
Stock Valuation VICO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
15.7823
Price Sales TTM
18.2725
Enterprise Value EBITDA
-4.3004
Price Book MRQ
5.0426
Financials VICO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VICO
For 52 weeks
7.02 SEK
24.43 SEK
50 Day MA
8.92 SEK
Shares Short Prior Month
–
200 Day MA
15.48 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart